Pharmaceutical Services | Home Page

News

- 08/08/2022 COVID-19 vaccines safety update

- 25/07/2022 EMA recommends restricting use of cancer medicine Rubraca

- 22/07/2022 EMA recommends approval of Imvanex for the prevention of monkeypox disease

- 12/07/2022 Updated joint statement from ECDC and EMA on additional booster doses of COVID-19 vaccines

- 12/07/2022 ECDC and EMA update recommendations on additional booster doses of mRNA COVID-19 vaccines

- 29/06/2022 Possible use of the vaccine Jynneos against infection by monkeypox virus

- 29/06/2022 EMA recommends authorisation of Nuvaxovid for adolescents aged 12 to 17

- 29/06/2022 EMA recommends Valneva’s COVID-19 vaccine for authorisation in the EU

- 29/06/2022 Monkeypox: EMA starts review for Imvanex

- 20/06/2022 Start of rolling review for adapted Spikevax COVID-19 vaccine